FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joachim Labenz

Research Profile

Disorders

Living Beings

Helicobacter pylori

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Andreas Leodolter; Tore Lind; Peter Malfertheiner; Marc Nocon; Kai Richter; Manfred Stolte; Michael Vieth; Stefan Willich; Daniel Jaspersen; Joachim Labenz
Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study.
Peter Malfertheiner; Marc Nocon; K Richter; Manfred Stolte; Michael Vieth; Daniel Jaspersen; H R Koelz; Joachim Labenz; Andreas Leodolter; Tore Lind; Stefan N Willich
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
S Krasz; S Miehlke; A Morgner; M Berning; Joachim Labenz
[Current value of quinolones in Helicobacter pylori therapy].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joachim Labenz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Andreas Leodolter; Tore Lind; Peter Malfertheiner; Marc Nocon; Kai Richter; Manfred Stolte; Michael Vieth; Stefan Willich; Daniel Jaspersen; Joachim Labenz
Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study.
Scandinavian journal of gastroenterology 2012;47(12):1429-35.
2012: Peter Malfertheiner; Marc Nocon; K Richter; Manfred Stolte; Michael Vieth; Daniel Jaspersen; H R Koelz; Joachim Labenz; Andreas Leodolter; Tore Lind; Stefan N Willich
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Alimentary pharmacology & therapeutics 2012;35(1):154-64.
2011: S Krasz; S Miehlke; A Morgner; M Berning; Joachim Labenz
[Current value of quinolones in Helicobacter pylori therapy].
Zeitschrift für Gastroenterologie 2011;49(8):989-96.
2011: Stephan Miehlke; S Löbe; A Madisch; E Kuhlisch; M Laass; D Grossmann; H Knoth; Andrea Morgner; Joachim Labenz
Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.
Alimentary pharmacology & therapeutics 2011;33(4):471-6.
2011: Ulrich Peitz; Thomas Wex; Michael Vieth; Manfred Stolte; Stefan Willich; Joachim Labenz; Daniel Jaspersen; Tore Lind; Peter Malfertheiner
Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study.
Journal of gastroenterology and hepatology 2011;26(1):82-9.
2010: Marco Berning; Susanne Krasz; Joachim Labenz; Stephan Miehlke
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance].
Medizinische Klinik (Munich, Germany : 1983) 2010;105(11):787-91.
2010: Joachim Labenz
[PPI withdrawal induces acid-related symptoms].
Zeitschrift für Gastroenterologie 2010;48(9):1153-5.
2009: Andreas Leodolter; Joachim Labenz
Ulcers: adjuvant PPIs to prevent major ulcer bleeds.
Nature reviews. Gastroenterology & hepatology 2009;6(8):446-7.
2009: Joachim Labenz; A Leodolter
[Gastro-oesophageal reflux disease].
MMW Fortschritte der Medizin 2009;151(14):40-4; quiz 45.
2009: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Andreas Leodolter; K Richter; Michael Vieth; Tore Lind; Peter Malfertheiner; Stefan N Willich
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study.
Alimentary pharmacology & therapeutics 2009;29(6):662-8.
2008: Neville D Yeomans; Angel Lanas; Joachim Labenz; Sander Veldhuyzen van Zanten; Christoffel van Rensburg; Istvan Rácz; Konstantin Tchernev; Dimitrios Karamanolis; Enrico Roda; Chris Hawkey; Emma Nauclér; Lars-Erik Svedberg
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
The American journal of gastroenterology 2008;103(10):2465-73.
2008: K Monkemuller; H Neumann; Marc Nocon; Michael Vieth; Joachim Labenz; Stefan N Willich; Manfred Stolte; M Hocker; Daniel Jaspersen; Tore Lind; Peter Malfertheiner
Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
Alimentary pharmacology & therapeutics 2008;28(4):491-6.
2008: Joachim Labenz
EMANCIPATE versus EXPO: different results can be explained by differing study designs.
European journal of gastroenterology & hepatology 2008;20(2):152; author reply 153-5.
2008: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Andreas Leodolter; Wolfgang Meyer-Sabellek; Manfred Stolte; Michael Vieth; Tore Lind; Peter Malfertheiner; Stefan N Willich
Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
Digestion 2008;77(2):69-72.
2007: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Manfred Stolte; Tore Lind; Peter Malfertheiner; Stefan N Willich
Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
Journal of gastroenterology and hepatology 2007;22(11):1728-31.
2007: Andrea Morgner; Joachim Labenz
How effective are PPIs for the treatment of patients with peptic ulcer bleeding?
Nature clinical practice. Gastroenterology & hepatology 2007;4(11):594-5.
2007: Hans-Martin Klein; Werner Meyners; Benjamin Neeb; Joachim Labenz; Karl-Heinz Truümmler
Cardiac magnetic resonance imaging using an open 0.35 T system.
Journal of computer assisted tomography 2007;31(3):430-4.
2007: Andrea Morgner; Stephan Miehlke; Joachim Labenz
Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers.
Expert opinion on pharmacotherapy 2007;8(7):975-88.
2007: Marc Nocon; Joachim Labenz; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Manfred Stolte; Tore Lind; Peter Malfertheiner; Stefan N Willich
Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study.
Alimentary pharmacology & therapeutics 2007;25(6):715-22.
2006: Joachim Labenz; Marc Nocon; Tore Lind; Andreas Leodolter; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Manfred Stolte; Michael Vieth; Stefan N Willich; Peter Malfertheiner
Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease.
The American journal of gastroenterology 2006;101(11):2457-62.
2006: Andrea Morgner; Joachim Labenz; Stephan Miehlke
Effective regimens for the treatment of Helicobacter pylori infection.
Expert opinion on investigational drugs 2006;15(9):995-1016.
2006: A Morgner-Miehlke; H Koop; André L Blum; M-L Hermans; Stephan Miehlke; Joachim Labenz
[Symptom- versus endoscopy-based diagnosis and treatment of gastroesophageal reflux disease (GERD)].
Zeitschrift für Gastroenterologie 2006;44(5):399-410.
2006: Daniel Jaspersen; Joachim Labenz; Stefan N Willich; Michael Kulig; Marc Nocon; Andreas Leodolter; Tore Lind; Wolfgang Meyer-Sabellek; Michael Vieth; M Stolte; Peter Malfertheiner
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(4):233-8.
2006: Stefan N Willich; Marc Nocon; Michael Kulig; Daniel Jaspersen; Joachim Labenz; Wolfgang Meyer-Sabellek; Manfred Stolte; Tore Lind; Peter Malfertheiner
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa.
Alimentary pharmacology & therapeutics 2006;23(3):371-6.
2006: Michael Vieth; Michael Kulig; Andreas Leodolter; Emma Nauclér; Daniel Jaspersen; Joachim Labenz; Wolfgang Meyer-Sabellek; Tore Lind; Stefan N Willich; Peter Malfertheiner; Manfred Stolte
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus.
Alimentary pharmacology & therapeutics 2006;23(2):313-9.
2006: Margrit Hollenz; Manfred Stolte; Andreas Leodolter; Joachim Labenz
NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care.
Digestive diseases (Basel, Switzerland) 2006;24(1-2):189-94.
2006: Marc Nocon; Joachim Labenz; Stefan N Willich
Lifestyle factors and symptoms of gastro-oesophageal reflux -- a population-based study.
Alimentary pharmacology & therapeutics 2006;23(1):169-74.
2006: Joachim Labenz; Andrea Morgner-Miehlke
An update on the available treatments for non-erosive reflux disease.
Expert opinion on pharmacotherapy 2006;7(1):47-56.
2005: Andreas Leodolter; Marc Nocon; Michael Kulig; Stefan N Willich; Peter Malfertheiner; Joachim Labenz
Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study.
World journal of gastroenterology : WJG 2005;11(45):7148-51.
2005: Ahmed Madisch; Stephan Miehlke; Joachim Labenz
Management of functional dyspepsia: Unsolved problems and new perspectives.
World journal of gastroenterology : WJG 2005;11(42):6577-81.
2005: Joachim Labenz; D Armstrong; Karsten Lauritsen; P Katelaris; S Schmidt; K Schütze; G Wallner; H Juergens; H Preiksaitis; N Keeling; Emma Nauclér; J Adler; S Eklund
Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
Alimentary pharmacology & therapeutics 2005;22(9):803-11.
2005: Joachim Labenz; Peter Malfertheiner
Treatment of uncomplicated reflux disease.
World journal of gastroenterology : WJG 2005;11(28):4291-9.
2005: Peter Malfertheiner; Tore Lind; Stefan N Willich; Michael Vieth; Daniel Jaspersen; Joachim Labenz; Wolfgang Meyer-Sabellek; Ola Junghard; Manfred Stolte
Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Gut 2005;54(6):746-51.
2005: Stephan Miehlke; Ahmed Madisch; Christian Kirsch; F Lindner; Eberhard Kuhlisch; Martin W Laass; H Knoth; Andrea Morgner; Joachim Labenz
Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.
Alimentary pharmacology & therapeutics 2005;21(8):963-7.
2005: Joachim Labenz; D Armstrong; Karsten Lauritsen; P Katelaris; S Schmidt; K Schütze; G Wallner; H Juergens; H Preiksaitis; N Keeling; Emma Nauclér; S Eklund
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.
Alimentary pharmacology & therapeutics 2005;21(6):739-46.
2004: Margrit Hollenz; Joachim Labenz
[Gastrointestinal complications under NSAID treatment in the doctor's office].
MMW Fortschritte der Medizin 2004;146(49):42, 44.
2004: Joachim Labenz; Daniel Jaspersen; Michael Kulig; Andreas Leodolter; Tore Lind; Wolfgang Meyer-Sabellek; Manfred Stolte; Michael Vieth; Stefan N Willich; Peter Malfertheiner
Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative.
The American journal of gastroenterology 2004;99(9):1652-6.
2004: Berndt R Birkner; Jürgen Hotz; Joachim Labenz; H Mönnikes; W Kölling; Margrit Hollenz; P Rodewyk; D Gater; D-K Koblitz; Peter Malfertheiner
[Short guideline for the management of dyspepsia].
Deutsche medizinische Wochenschrift (1946) 2004;129(18):1032-4.
2004: Michael Vieth; Ulrich Peitz; Joachim Labenz; Michael Kulig; Emma Nauclér; Daniel Jaspersen; Wolfgang Meyer-Sabellek; Stefan N Willich; Tore Lind; Peter Malfertheiner; Manfred Stolte
What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa?
Digestive diseases (Basel, Switzerland) 2004;22(2):196-201.
2003: Ahmed Madisch; Károly R Kulich; P Malfertheiner; K Ziegler; Ekkehard Bayerdörffer; Stephan Miehlke; Joachim Labenz; J Carlsson; Ingela Wiklund
Impact of reflux disease on general and disease-related quality of life - evidence from a recent comparative methodological study in Germany.
Zeitschrift für Gastroenterologie 2003;41(12):1137-43.
2003: Joachim Labenz; Karl-Uwe Petersen; W Rösch; Hans R Koelz
["Mirror, mirror on the wall which is the best proton pump inhibitor of all?"].
Zeitschrift für Gastroenterologie 2003;41(11):1123.
2003: Michael Kulig; Andreas Leodolter; Michael Vieth; E Schulte; Daniel Jaspersen; Joachim Labenz; Tore Lind; Wolfgang Meyer-Sabellek; Peter Malfertheiner; Manfred Stolte; Stefan N Willich
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.
Alimentary pharmacology & therapeutics 2003;18(8):767-76.
2003: Daniel Jaspersen; Michael Kulig; Joachim Labenz; Andreas Leodolter; Tore Lind; Wolfgang Meyer-Sabellek; Michael Vieth; Stefan N Willich; D Lindner; M Stolte; P Malfertheiner
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study.
Alimentary pharmacology & therapeutics 2003;17(12):1515-20.
2003: Joachim Labenz; Karl-Uwe Petersen; W Rösch; Hans R Koelz
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
Alimentary pharmacology & therapeutics 2003;17(8):1015-9.
2003: Károly R Kulich; Peter Malfertheiner; Ahmed Madisch; Joachim Labenz; Ekkehard Bayerdörffer; Stephan Miehlke; Jonas Carlsson; Ingela Wiklund
Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease.
Health and quality of life outcomes 2003;1():62.
2002: Joachim Labenz; André L Blum; W W Bolten; Brigitte Dragosics; W Rösch; Manfred Stolte; Hans R Koelz
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Gut 2002;51(3):329-35.
2002: Joachim Labenz
[Proton pump inhibitors according to need. Always for heartburn].
MMW Fortschritte der Medizin 2002;144(23):34-7.
2002: Margrit Hollenz; Manfred Stolte; Joachim Labenz
[Prevalence of gastro-oesophageal reflux disease in general practice].
Deutsche medizinische Wochenschrift (1946) 2002;127(19):1007-12.
2002: Ulrich Peitz; M Sulliga; Kathlen Wolle; Andreas Leodolter; Ulrike von Arnim; Stefan Kahl; Manfred Stolte; G Börsch; Joachim Labenz; Peter Malfertheiner
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
Alimentary pharmacology & therapeutics 2002;16(2):315-24.
2001: Ulrich Peitz; M Baumann; B Tillenburg; G Börsch; Manfred Stolte; Peter Malfertheiner; Joachim Labenz
[Insufficient validity of a rapid blood test for diagnosis of Helicobacter pylori infection].
Medizinische Klinik (Munich, Germany : 1983) 2001;96(12):703-7.
2001: Stephan Miehlke; Christian Kirsch; Brigitte Dragosics; Michael Gschwantler; Georg Oberhuber; David Antos; P Dite; J Läuter; Joachim Labenz; A Leodolter; Peter Malfertheiner; Andreas Neubauer; Gerhard Ehninger; Manfred Stolte; Ekkehard Bayerdörffer
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
World journal of gastroenterology : WJG 2001;7(2):243-7.
2000: Sander Veldhuyzen van Zanten; Karsten Lauritsen; JC Delchier; Joachim Labenz; C M De Argila; Tore Lind; H C Treichel; A Stubberöd; Alan Cockeram; Göran Hasselgren; L Göthe; Michael Wrangstadh; Paul Sinclair
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease.
Alimentary pharmacology & therapeutics 2000;14(12):1605-11.
2000: Joachim Labenz
Consequences of Helicobacter pylori cure in ulcer patients.
Baillière's best practice & research. Clinical gastroenterology 2000;14(1):133-45.
1999: Joachim Labenz; M Stolte
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
Zeitschrift für Gastroenterologie 1999;37(7):649-52.
1999: Ekkehard Bayerdörffer; Stephan Miehlke; Joachim Labenz; Alexander Meining; Brigitte Dragosics; G Oberhuber; J Läuter; Andreas Neubauer; P Malfertheiner; M Stolte
[Prevention of stomach carcinoma by Helicobacter pylori eradication. Invitation to participate in the PRISMA Study].
Zeitschrift für Gastroenterologie 1999;37(5):XXI-XXV.
1999: Joachim Labenz; Ulrich Peitz; H Köhl; J Kaiser; Peter Malfertheiner; Andreas Hackelsberger; G Börsch
Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
Italian journal of gastroenterology and hepatology 1999;31(2):110-5.
1999: Margrit Hollenz; Manfred Stolte; Joachim Labenz
[Helicobacter pylori screening in a general practice].
Deutsche medizinische Wochenschrift (1946) 1999;124(7):171-5.
1998: André L Blum; Nicholas J Talley; C O'Moráin; Sander Veldhuyzen van Zanten; Joachim Labenz; Manfred Stolte; J A Louw; A Stubberöd; A Theodórs; Marie Sundin; Elisabeth Bolling-Sternevald; Ola Junghard
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
The New England journal of medicine 1998;339(26):1875-81.
1998: Gianpiero Manes; J Enrique Domínguez-Muñoz; Generoso Uomo; Joachim Labenz; Andreas Hackelsberger; P Malfertheiner
Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study.
Italian journal of gastroenterology and hepatology 1998;30(1):28-33.
1997: Andreas Hackelsberger; Thomas Günther; V Schultze; Joachim Labenz; Albert Roessner; Peter Malfertheiner
Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia.
The American journal of gastroenterology 1997;92(12):2220-4.
1997: Joachim Labenz; Peter Malfertheiner
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?
Gut 1997;41(3):277-80.
1997: Joachim Labenz; B Tillenburg; Ulrich Peitz; Elena F Verdú; Manfred Stolte; G Börsch; André L Blum
Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
Gut 1997;41(1):33-6.
1997: Joachim Labenz; Peter Malfertheiner
[Helicobacter pylori--when and how do gastroenterologists treat themselves? A clinical and practical survey].
Deutsche medizinische Wochenschrift (1946) 1997;122(20):637-42.
1997: Joachim Labenz; André L Blum; E Bayerdörffer; A Meining; Manfred Stolte; G Börsch
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.
Gastroenterology 1997;112(5):1442-7.
1997: Joachim Labenz; B Tillenburg; Ulrich Peitz; G Börsch; JP Idström; Elena F Verdú; Manfred Stolte; André L Blum
Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients.
The American journal of gastroenterology 1997;92(4):576-81.
1997: B Tillenburg; S Siehoff; T Becker; Ulrich Peitz; G Börsch; Joachim Labenz
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)].
Zeitschrift für Gastroenterologie 1997;35(3):165-9.
1997: Joachim Labenz; B Tillenburg; J Weismüller; A Lütke; Manfred Stolte
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
Alimentary pharmacology & therapeutics 1997;11(1):95-100.
1997: Joachim Labenz; JP Idström; B Tillenburg; Ulrich Peitz; R J Adamek; G Börsch
One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers.
Alimentary pharmacology & therapeutics 1997;11(1):89-93.
1997: Joachim Labenz; Ulrich Peitz; C Leusing; B Tillenburg; André L Blum; G Börsch
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
Gut 1997;40(1):36-41.
1996: Elena F Verdú; D Armstrong; JP Idström; Joachim Labenz; M Stolte; G Börsch; André L Blum
Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis.
Scandinavian journal of gastroenterology 1996;31(12):1151-6.
1996: Joachim Labenz; G Bärsch; Ulrich Peitz; S Aygen; O Hennemann; B Tillenburg; T Becker; M Stolte
Validity of a novel biopsy urease test (HUT) and a simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis.
Digestion 1996;57(6):391-7.
1996: Elena F Verdú; P Bercík; D Armstrong; Joachim Labenz; André L Blum
Helicobacter pylori infection and omeprazole efficacy.
Gastroenterology 1996;111(5):1401-2.
1996: Joachim Labenz
[Current developments in Helicobacter pylori therapy].
Leber, Magen, Darm 1996;26(4):223-6.
1996: Joachim Labenz; M Stolte; Ulrich Peitz; B Tillenburg; T Becker; G Börsch
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Alimentary pharmacology & therapeutics 1996;10(2):207-10.
1996: Joachim Labenz; B Tillenburg; Ulrich Peitz; JP Idström; Elena F Verdú; M Stolte; G Börsch; André L Blum
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.
Gastroenterology 1996;110(3):725-32.
1996: Joachim Labenz; B Tillenburg; Ulrich Peitz; H Köhl; T Becker; M Stolte; G Börsch
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Deutsche medizinische Wochenschrift (1946) 1996;121(1-2):3-7; discussion 7-8.
1996: Joachim Labenz; B Tillenburg; Ulrich Peitz; G Börsch
Long-term consequences of Helicobacter pylori eradication: clinical aspects.
Scandinavian journal of gastroenterology. Supplement 1996;215():111-5.
1995: Elena F Verdú; D Armstrong; JP Idström; Joachim Labenz; M Stolte; Gian Dorta; G Börsch; André L Blum
Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.
Gut 1995;37(6):743-8.
1995: Joachim Labenz; M Stolte; Ulrich Peitz; B Tillenburg; H Köhl; T Becker; G Börsch
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Zeitschrift für Gastroenterologie 1995;33(10):590-3.
1995: Joachim Labenz; B Tillenburg; Ulrich Peitz; H Köhl; G Börsch
Eradication rate of Helicobacter pylori.
Gut 1995;37(4):591; author reply 592.
1995: Joachim Labenz; M Stolte; A L Blum; I Jorias; F Leverkus; M Sollböhmer; J Bertrams; G Börsch
Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.
Gut 1995;37(1):39-43.
1995: Joachim Labenz; Ulrich Peitz; B Tillenburg; T Becker; G Börsch; M Stolte
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].
Leber, Magen, Darm 1995;25(3):122, 125-7.
1995: Joachim Labenz
[Differential aggressiveness of Helicobacter pylori].
Bildgebung = Imaging 1995;62 Suppl 1():59-60.
1995: Joachim Labenz; M Stolte; C Domian; J Bertrams; G Börsch
High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
Digestion 1995;56(1):14-20.
1995: Joachim Labenz; M Stolte
[Vision and hearing disorders with omeprazole: the facts].
Leber, Magen, Darm 1995;25(1):6-8, 11.
1995: Joachim Labenz; B Tillenburg; Ulrich Peitz; M Stolte; G Börsch
[Bleeding peptic ulcers--how can recurrent bleeding be prevented?].
Leber, Magen, Darm 1995;25(1):27-33.
1995: Joachim Labenz; M Stolte; G H Rühl; T Becker; B Tillenburg; M Sollböhmer; G Börsch
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection.
European journal of gastroenterology & hepatology 1995;7(1):9-11.
1994: Joachim Labenz; F Leverkus; G Börsch
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.
Scandinavian journal of gastroenterology 1994;29(12):1070-5.
1994: Romuald J Adamek; Marcus Freitag; Joachim Labenz; W Opferkuch; G H Rühl; S Aygen; O Hennemann; M Wegener
[The modified 13C-urea breath test in the diagnosis of Helicobacter pylori colonization of the gastric mucosa].
Deutsche medizinische Wochenschrift (1946) 1994;119(46):1569-72.
1994: Joachim Labenz; G Börsch
[Is ulcer disease an infectious disease?].
Deutsche medizinische Wochenschrift (1946) 1994;119(43):1488-9.
1994: Joachim Labenz; G Börsch
Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
The American journal of gastroenterology 1994;89(10):1785-8.
1994: Joachim Labenz; I Jorias; M Sollböhmer; U Peitz; M Stolte; G Börsch
[24-hour gastric pH profile with 2 x 20 mg and 2 x 40 mg omeprazole in patients with Helicobacter pylori-associated gastroduodenal ulcer disease].
Zeitschrift für Gastroenterologie 1994;32(8):436-40.
1994: Joachim Labenz; G H Rühl; J Bertrams; G Börsch
Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease.
Digestive diseases and sciences 1994;39(7):1483-7.
1994: Joachim Labenz; G H Rühl; J Bertrams; G Börsch
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Alimentary pharmacology & therapeutics 1994;8(3):323-7.
1994: Joachim Labenz; G Börsch
[The therapy of Helicobacter pylori infection].
Deutsche medizinische Wochenschrift (1946) 1994;119(18):669-72.
1994: S Madeya; Joachim Labenz; H Breining; Ulrich Peitz; J Korth; G Börsch
[Hepatocellular carcinoma following intravenous thorium X therapy].
Deutsche medizinische Wochenschrift (1946) 1994;119(18):653-6.
1994: Joachim Labenz; G H Rühl; J Bertrams; G Börsch
Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.
The American journal of gastroenterology 1994;89(5):726-30.
1994: Joachim Labenz; G Börsch
[Clinical aspect and diagnosis of Helicobacter pylori infection].
Deutsche medizinische Wochenschrift (1946) 1994;119(17):633-6.
1994: Joachim Labenz; M Wegener; Romuald J Adamek; W Opferkuch; G H Rühl; G Börsch
[Omeprazole modified antibiotic therapy of Helicobacter pylori infection: can clarithromycin be replaced by roxithromycin?].
Leber, Magen, Darm 1994;24(2):73-5.
1994: Romuald J Adamek; M Wegener; Joachim Labenz; Marcus Freitag; W Opferkuch; G H Rühl
Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy.
The American journal of gastroenterology 1994;89(1):39-42.
1994: Joachim Labenz; G Börsch
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Digestion 1994;55(1):19-23.
1993: Joachim Labenz; E Gyenes; G H Rühl; G Börsch
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Gut 1993;34(9):1167-70.
1993: Joachim Labenz; Ulrich Peitz; S Madeya; M Wieczorek; J Erdelkamp; G Börsch
[Arthralgia, weight loss and polyserositis as chief symptoms of Whipple's disease].
Medizinische Klinik (Munich, Germany : 1983) 1993;88(7):427-31; 448.
1993: Joachim Labenz; M Stolte; S Aygen; O Hennemann; J Bertrams; G Börsch
[Qualitative and semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa].
Zeitschrift für Gastroenterologie 1993;31(7-8):437-43.
1993: Joachim Labenz; E Gyenes; G H Rühl; G Börsch
[Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease].
Medizinische Klinik (Munich, Germany : 1983) 1993;88(5):297-9.
1993: Joachim Labenz; E Gyenes; G H Rühl; G Börsch
Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori.
The American journal of gastroenterology 1993;88(4):491-5.
1993: Joachim Labenz; G Börsch
Bleeding watermelon stomach treated by Nd-YAG laser photocoagulation.
Endoscopy 1993;25(3):240-2.
1993: Joachim Labenz; E Gyenes; G H Rühl; M Wieczorek; J Hluchy; G Börsch
[Is Helicobacter pylori gastritis a macroscopic diagnosis?].
Deutsche medizinische Wochenschrift (1946) 1993;118(6):176-80.
1992: Joachim Labenz; E Gyenes; G H Rühl; G Börsch
Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori.
Zeitschrift für Gastroenterologie 1992;30(11):776-8.
1992: Joachim Labenz; G Börsch
[Bleeding gastric and duodenal varicose veins: endoscopic embolisation using tissue adhesives].
Deutsche medizinische Wochenschrift (1946) 1992;117(34):1274-7.
1992: Joachim Labenz; G Börsch
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Deutsche medizinische Wochenschrift (1946) 1992;117(25):997-9.
1992: Joachim Labenz; E Gyenes; G H Rühl; G Börsch
[Short-term therapy with high dosage omeprazole and amoxicillin for Helicobacter pylori eradication. A pilot study].
Medizinische Klinik (Munich, Germany : 1983) 1992;87(3):118-9.
1991: Joachim Labenz; E Gyenes; G Rühl; Ulrich Peitz; G Börsch
[Diagnosis of Helicobacter pylori colonization of the gastric mucosa. A prospective comparative study of direct test methods and validation of a new urease test].
Medizinische Klinik (Munich, Germany : 1983) 1991;86(9):461-4.
1991: S Madeya; Joachim Labenz; G Börsch
[Alcohol-induced ketoacidosis. Part 2: Therapy, follow-up and pathogenetic theories].
Fortschritte der Medizin 1991;109(24):480-1.
1991: S Madeya; Joachim Labenz; G Börsch
[Alcohol-induced ketoacidosis. 1: symptoms, diagnosis, differential diagnosis].
Fortschritte der Medizin 1991;109(23):465-6.
1991: Joachim Labenz; E Gyenes; Ulrich Peitz; G Börsch
[Ciprofloxacin-omeprazole combination therapy for eradication of Helicobacter pylori].
Zeitschrift für Gastroenterologie 1991;29(4):143-5.
1990: Joachim Labenz; G Hopmann; F Leverkus; G Börsch
[Bowel cleansing prior to colonoscopy. A prospective, randomized, blind comparative study].
Medizinische Klinik (Munich, Germany : 1983) 1990;85(10):581-5.
1990: Joachim Labenz; G Börsch
[Vascular anomalies as the cause of recurrent intestinal hemorrhages].
Deutsche medizinische Wochenschrift (1946) 1990;115(15):575-9.